Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2016 Feb;25(2):344–350. doi: 10.1158/1055-9965.EPI-15-0470

Table 3.

Associations between patient characteristics and time to colonoscopy follow-up after positive fecal occult blood test in PROSPR healthcare systems, 2011–2012 (47,827)a

Characteristic at positive fecal occult blood test Hazard ratio (95% confidence interval)
Age (years)
 50–54 Reference
 55–59 1.02 (0.98–1.05)
 60–64 0.98 (0.95–1.02)
 65–69 0.98 (0.95–1.02)
 70–75 0.90 (0.87–0.94)
 76–84 0.65 (0.61–0.69)
 85–89 0.34 (0.29–0.39)
Gender
 Female Reference
 Male 1.03 (1.00–1.05)
Charlson comorbidity score
 0 Reference
 1 0.93 (0.91–0.96)
 2 0.87 (0.84–0.90)
 ≥3 0.70 (0.67–0.72)
Body mass index (kg/m2)
 <25 Reference
 25 to <30 1.06 (1.03–1.09)
 30 to <35 1.07 (1.04–1.10)
 ≥35 1.01 (0.97–1.04)
Race/ethnicity
 White, non-Hispanic Reference
 Hispanic (any race) 1.01 (0.98–1.04)
 Asian/Pacific Islander 0.97 (0.94–1.00)
 Black 0.98 (0.94–1.02)
 Other 0.96 (0.84–1.09)
Prior colorectal cancer screening
 No Reference
 Yes 1.30 (1.26–1.34)
Healthcare system
 Kaiser Permanente Southern California Reference
 Group Health 0.64 (0.61–0.68)
 Kaiser Permanente Northern California 0.99 (0.97–1.01)
 Parkland Health and Hospital System – University of Texas Southwestern Medical Center 0.24 (0.18–0.32)
a

Multivariate regression limited to persons with complete covariate information

PROSPR: Population-Based Research Optimizing Screening through Personalized Regimens